Diversity of human African trypanosomiasis epidemiological settings requires fine-tuning control strategies to facilitate disease elimination by Simarro PP, Franco JR, Diarra A, Ruiz Postigo JA, Jannin J

Get full text

Monitoring the use of nifurtimox-eflornithine combination therapy (NECT) in the treatment of second stage gambiense human African trypanosomiasis by Franco JR, Simarro PP, Diarra A, Ruiz-Postigo JA, Samo M, Jannin JG

Get full text

Relationship of serum antileishmanial antibody with development of visceral leishmaniasis, post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse by Mondal, D, Ghosh, P, Chowdhury, R, Halleux, C, Ruiz-Postigo, JA, Alim, A, Hossain, F, Khan, MAA, Nath, R, Duthie, MS, Kroeger, A, Matlashewski, G, Argaw, D, Olliaro, P

Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation by Olliaro, P, Grogl, M, Boni, M, Carvalho, EM, Chebli, H, Cisse, M, Diro, E, Cota, G, Erber, AC, Gadisa, E, Handjani, F, Khamesipour, A, Llanos-Cuentas, A, Carvajal, L, Grout, L, Lmimouni, BE, Mokni, M, Nahzat, MS, Salah, A, Ozbel, Y, Pascale, JM, Molina, N, Rode, J, Romero, G, Ruiz-Postigo, JA